Johnson & Johnson Begins Study of One-Dose Covid Shot

Johnson & Johnson has begun dosing up to 60,000 volunteers in a study of its Covid-19 vaccine, marking the first big U.S. trial of an inoculation that may work after just one shot. Bloomberg’s Robert Langreth reports on “Bloomberg Markets.”
Bloomberg Markets News video.

____________________

Covid 19 Virus Defend Systems from EcoTechN.com

______________

NEW YORK MIDTOWN TRIBUNE NEWS POLITICS 

BUSINESS SOCIETY CRIME CULTURE USA